Clinical Studies
Patients have numerous medical care options but often feel uncertain about their choices in our rapidly changing healthcare environment. You will find more cutting-edge, innovative medical and surgical technologies at Vold Vision’s Research Center than at most major academic medical centers.
Research and Clinical Studies
As global innovation and clinical research leaders, we utilize medical technologies found only at a few eye care centers worldwide. We at Vold vision seek to serve you in such a way that you know that our passion for caring for people drives our motivation.
Our doctors have participated in nearly 20 FDA-approved clinical trials in the past year. These studies include the development of innovative surgical devices and techniques, pharmaceutical products, and drug delivery systems.
Our specific areas of interest include minimally invasive glaucoma surgery, lens replacement (cataract) surgery, and the development of new medications and methods of drug delivery for glaucoma, intraocular inflammation, dry eyes, and infection treatments.
Many of these products have received approval in Europe and Canada but are currently unavailable in the United States. The clinical studies allow us to provide enhanced ophthalmic care at no cost to the patients.
There are many benefits to participating in clinical studies.
Watch this video to discover more.
There are many benefits to participating in clinical studies.
Watch this video to discover more.
Benefits to Patients
Participation in ophthalmic research and innovation is integral to our clinical practice at Vold Vision. We strongly believe that research and innovation enhance patient care and allow us to give back to our patients and society.
With nearly 20 years of clinical research experience, we have found that our patients benefit tremendously from our clinical research programs. We are excited about the breakthrough technologies we might provide in the months and years ahead. The motivation of our efforts at Vold Vision is to serve you better and improve ophthalmic care throughout the world.
Vold Vision is selective in our choices of clinical studies. After carefully reading the protocol, we select studies to ensure the studies are grounded in solid scientific evidence. We want only the best for our patients and the eye care industry.
Vold Vision consistently participates in clinical studies. Patients who participate are compensated for their time and efforts and play a significant role in advancing vision care.
Are you interested in participating in a current clinical study?
Vold Vision is currently enrolling for multiple FDA clinical studies. If you would like to learn if you are a research candidate, call Vold Vision at 479-442-8653 and ask for Corinna or Iryna.
Past Clinical Studies
Clinical Evaluation of the SOLX GoldShunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma [Protocol SLX 84]
Sponsor: SOLX, Inc.
Clinical Investigation of AcrySof® IQ Monofocal Toric Intraocular Lens Model SN6AT2. [Protocol: C-09-076]
Sponsor: Alcon
Comparative Study of the Safety and Effectiveness of Ologen®Collagen Matrix versus Mitomycin_C in Glaucome Filtering Surgery [Protocol ologen – 2009-02]
Sponsor: Aeon Astron Europe B.V.
The Efficacy and Safety of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension [Protocol 192024-092]
Sponsor: Allergan
Evaluation of Bimatoprost 0.01% and Bimatoprost 0.03% in Patients with Glaucoma and Ocular Hypertension [Protocol 192024-081]
Sponsor: Allergan
Take the Next Step
To schedule a consultation, fill out the consultation request form below, or call or text (479) 442-8653.
